Management of peritonitis in children receiving chronic peritoneal dialysis

Pediatric Drugs

Volumn 5, Issue 5, 2003, Pages 315-325

  Schaefer, Franz ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPHOTERICIN B; AMPICILLIN; AZLOCILLIN; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; FLUCYTOSINE; GENTAMICIN; GLYCOPEPTIDE; METRONIDAZOLE; NETILMICIN; OXACILLIN; PIPERACILLIN; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; BACTERIUM CULTURE; CHILD; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG EFFICACY; DRUG HALF LIFE; EPIDEMIOLOGICAL DATA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMPLANTATION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LONG TERM CARE; MYCOSIS; NEPHROTOXICITY; OTOTOXICITY; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REVIEW; RISK FACTOR; SKIN IRRITATION; STAPHYLOCOCCUS AUREUS; TECHNIQUE;

EID: 0037903360     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200305050-00004     Document Type: Review

References (65)

1. Schaubel DE, Blake PG, Fenton SS. Trends in CAPD technique failure: Canada, 1981-1997. Perit Dial Int 2001; 21: 365-71
2. Edefonti A, Consalvo G, Pappalettera M. Infectious complications in paediatric patients treated with chronic peritoneal dialysis (CPD). Perit Dial Int 1996; 16: 543-7
3. Lederman S, Scanes ME, Fernando ON, et al. Long-term outcome of peritoneal dialysis in infants. J Pediatr 2000; 136: 24-9
4. Hoshii S, Honda M, Itami B, et al. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol 2000; 14: 275-9
5. Warady BA, Schaefer F, Holloway M, et al. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int 2000; 10: 610-24
6. International Pediatric Peritonitis Registry [online]. Available from URL: www.peritonitis.org [Accessed 2003 Mar 3]
7. Burkart JM, Hylander B, Durnell-Figel T, et al. Comparison of peritonitis rates during long-term use of standard spike versus Ultraset in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10: 41-3
8. Burkart JM, Jordan JR, Durnell TA, et al. Comparison of exit-site infections in disconnect versus nondisconnect systems for peritoneal dialysis. Perit Dial Int 1992; 12: 317-20
9. Valeri A, Radhakrishnan J, Vernocci L, et al. The epidemiology of peritonitis in acute peritoneal dialysis: a comparison between open- and closed-drainage systems. Am J Kidney Dis 1993; 21: 300-9
10. Monteon F, Correa-Rotter R, Paniagua R, et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. Kidney Int 1998; 54: 2123-8
11. Howard RL. Millspaugh J, Teitelbaum I. Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis. Am J Kidney Dis 1990; 16: 469-72
12. Schaefer F, Klaus G, Müller-Wiefel DE, et al. Current practice of peritoneal dialysis in children: results of a longitudinal survey. Perit Dial Int 1999; 19 Suppl. 2: S445-9
13. Verrina E, Bassi S, Perfumo F, et al. Analysis of complications in a chronic peritoneal dialysis pediatric patient population. The Italian Registry of Pediatric Chronic Peritoneal Dialysis. Perit Dial Int 1993; 13: S257-9
14. Furth SL, Donaldson LA, Sullivan EK, et al. Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 2000; 15: 179-82
15. Honda M, Iitaka K, Kawaguchi H, et al. The Japanese National Registry data on pediatric CAPD patients: a ten-year experience: a report of the Study Group of Pediatric PD Conference. Perit Dial Int 1996; 16: 269-75
16. Kawaguchi Y. National comparisons: optimal peritoneal dialysis outcomes among Japanese patients. Perit Dial Int 1999; 19: S9-16
17. Tranaeus A. Peritonitis in paediatric continuous peritoneal dialysis. In: Fine RN, Alexander SR, Warady BA, editors. CAPD/CCPD in children. Boston (MA): Kluwer Academic Publishers, 1998: 301-47
18. Warady BA, Sullivan EK, Alexander SR. Lessons from the peritoneal dialysis patient database: a report of the North American pediatric renal transplant cooperative study. Kidney Int 1996; 49 Suppl. 53: S68-71
19. Warady BA, Hebert D, Sullivan EK, et al. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents: the 1995 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997; 11: 49-64
20. Lerner GR, Warady BA, Sullivan EK, et al. Chronic dialysis in children and adolescents: the 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1999; 13: 404-17
21. Schaefer F, Klaus G. Müller-Wiefel DE, et al. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. J Am Soc Nephrol 1999; 10: 136-45
22. Zelenitsky S, Barns L, Findlay I, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36: 1009-13
23. Schröder CH, Bakkeren JA, Weemaes CM, et al. IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9: 261-5
24. Neu AM, Furth SL, Ledermann HM, et al. Hypogammaglobulinemia in infants on peritoneal dialysis. Perit Dial Int 1998; 18: 440-3
25. Bouts AHM, Davin JC, Krediet RT, et al. Immunoglobulins in chronic renal failure of childhood: effects of dialysis modalities. Kidney Int 2000; 58: 629-37
26. Cameron JS. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis. Pediatr Nephrol 1995; 9: 647-62
27. Schaefer F, Kandert M, Feneberg R. Methodological issues in assessing peritonitis incidence in children. Perit Dial Int 2002; 22: 234-8
28. Keane WF, Bailie GR, Boeschoten E, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000; 20: 396-411
29. Chan MK, Chow L, Lam SS, et al. Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis 1988; 11: 180-3
30. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidermiol 1995; 16: 105-13
31. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 316: 927-31
32. Sieradzki K, Roberts RB, Haber SW, et al. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999; 340: 517-23
33. von Baum H, Schehl J, Geiss HK, et al. Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Clin Infect Dis 1999; 29: 912-6
34. Mancini ML, Dello Strologo L, Bianchi PM, et al. Sensotineural hearing loss in patients reaching chronic renal failure in childhood. Pediatr Nephrol 1996; 10: 38-40
35. Shemin D, Maaz D, St Pierre D, et al. Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 1999; 31: 14-20
36. Singhal MK, Bhaskaran S, Vidgen E, et al. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 2000; 20: 429-38
37. Mantley HJ, Bailie G, Asher RD, et al. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19: 65-70
38. Grabe DW, Bailie GR, Eisele G, et al. Pharmacokinetics of intermittent intraperitoneal ceftazidime. Am J Kidney Dis 1999; 33: 111-7
39. Low CL, Gopalakrishna K, Lye WC. Pharmacokinetics of once daily intraperitoneal cefaxolin in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2000; 11: 1117-21
40. Gokal R, Alexander S, Ash S, et al. Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update (official report from the International Society for Peritoneal Dialysis). Perit Dial Int 1998; 18: 11-33
41. Vychytil A, Lorenz M, Schneider B, et al. New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography. J Am Soc Nephrol 1998; 9: 290-6
42. Montane BS, Mazza I, Abitbol C, et al. Fungal peritonitis in pediatric patients. Adv Perit Dial 1998; 14: 251-4
43. Warady BA, Bashir M, Donaldson LA. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int 2000; 58: 384-9
44. Robitaille P, Merouani A, Clermont MJ, et al. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995; 15: 77-9
45. de Boer AW, Levi M, Reddingius RE, et al. Intraperitoneal hypercoagulation and hypofibrinolysis is present in childhood peritonitis. Pediatr Nephrol 1999; 13: 284-7
46. Williams AJ, Boletis I, Johnson BF, et al. Tenckhoff catheter replacement or intraperitoneal urokinase: a randomized trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Perit Dial Int 1989; 9: 65-7
47. Klaus G, Schaefer F, Querfeld U, et al. Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis. Adv Perit Dial 1992; 8: 302-5
48. Innes A, Burden RP, Finch RG, et al. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial. Nephrol Dial Transplant 1994; 9: 797-9
49. Rinaldi S, Sera F, Verrina E, et al. The Italian Registry of Pediatric Chronic Peritoneal Dialysis: a ten-year experience with chronic peritoneal dialysis catheters. Perit Dial Int 1998; 18: 71-4
50. Holloway M, Mujais S, Kandert M, et al. Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates. Perit Dial Int 2001; 21: 401-4
51. Kerrina E, Honda M, Warady BA, et al. Prevention of peritonitis in children on peritoneal dialysis. Perit Dial Int 2000; 20: 625-30
52. Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2403-8
53. Oh J, von Baum H, Klaus G, et al. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. Adv Perit Dial 2000; 16: 324-7
54. Oh J, von Baum H, Wuhl E, et al. Nasal mupirocin prophylaxis reduces the incidence of PD-related S. aureus infections in children: results of a double-blind, placebo-controlled multicenter trial [abstract]. Perit Dial Int 2002; 22: S74
55. Bernardini J, Piraino B, Holley J, et al. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695-700
56. Thodis E, Bhaskaran S, Pasadakis P, et al. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998; 18: 261-70
57. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, et al. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39: 337-41
58. Annigeri R, Conly J, Vas S, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21: 554-9
59. Sedlok DM, Bailey DM. Microbicidal activity of octenidine hydrochloride, a new alkanediylbis [pyridine] germicidal agent. Antimicrob Agents Chemother 1985; 28: 786-90
60. Sloot N, Siebert J, Hoffler U. Eradication of MRSA from carriers by means of whole-body washing with an antiseptic in combination with mupirocin nasal ointment. Zentralbl Hyg Umweltmed 1999; 202: 513-23
61. Rengelshausen J, Nurnberger J, Philipp T, et al. Decolonization of methicillin-resistant Staphylococcus aureus by disinfection of the skin. Am J Med 2000; 108: 685-6
62. Vas S. The need for antibacterial prophylaxis during peritoneal dialysis. Perit Dial Int 1999; 19: 197-8
63. Fried L, Bernardini J, Piraino B. Iatrogenic peritonitis: the need for prophylaxis. Perit Dial Int 2000; 20: 343-5
64. Sardegna KM, Beck AM, Strife CF. Evaluation of perioperative antibacterials at the time of dialysis catheter placement. Pediatr Nephrol 1998; 12: 149-52
65. Watson AR, Gartland C, European Pediatric Peritoneal Dialysis Working Group. Guidelines by an ad hoc European committee for elective chronic peritoneal dialysis in pediatric patients. Perit Dial Int 2001; 21: 240-4